Stryker completes acquisition of cerus endovascular

Kalamazoo, michigan, usa, may 2, 2023 /prnewswire/ -- stryker (nyse:syk), one of the world's leading medical technology companies, announced today that it has completed the acquisition of cerus endovascular ltd., a privately held, commercial-stage, medical device company engaged in the design and development of neurointerventional devices for the treatment of intracranial aneurysms.
SYK Ratings Summary
SYK Quant Ranking